AzTrials
AzTrials

Myofascial PainNCT04257903

Different Treatment Modalities for Myofascial Pain

An observational study of Myofascial Pain and Splints, run by Trakya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Myofascial pain dysfunction syndrome (MPDS) is the most common reason for pain and limited function of the masticatory system. The low-level laser therapy (LLLT) and occlusal splint therapy (OST) are therapeutic options for MPDS. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Myofascial Pain, Splints, Low-Level Laser Therapy
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2019to 1 Apr 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Adult

Study population: Thracian region

Who may be able to join

  • Diagnosis of myofascial pain syndrome according to The Research Diagnostic Criteria for Temporomandibular Disorder.
  • Individuals between the ages of 18-60
  • Occlusion of individuals with posterior teeth
  • Forms of individuals who do not have any systemic disease

Who cannot join

  • Disc displacement with or without reduction, with or without limited mouth opening, arthralgia, arthritis, arthrosis
  • Inflammatory connective tissue disease (such as rheumatoid arthritis)
  • Psychiatric diseases
  • Tumor
  • Heart diseases
  • Pregnancy
Show all 9Show fewer
  • Diseases that may cause pain symptoms in other orofacial regions (toothache, neuralgia, migraine)
  • Having received any treatment for headache or bruxism in the last 2 years
  • Skin infections on the masseter and temporal muscles

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Trakya University

    Merkez, Edirne, 22030

Other trials in Turkey (Türkiye)

About this study

Official title: Effectiveness of Different Treatment Methods in Patients With Myofascial Pain Syndrome

Myofascial pain dysfunction syndrome (MPDS) is the most common reason for pain and limited function of the masticatory system. The low-level laser therapy (LLLT) and occlusal splint therapy (OST) are therapeutic options for MPDS. This study aims to evaluate the effect of LLLT and OST on pain relief and mandibular movement improvement in patients with myofascial pain.

Read the detailed description

Myofascial pain dysfunction syndrome in the masticatory muscles is the most common temporomandibular disorder. Patients suffer from pain and muscle tenderness and may present with or without restricted mouth opening. The etiology of myofascial pain dysfunction syndrome is multifactorial including psychological factors, occlusion imbalance, and parafunctional habits. Treatments for myofascial pain dysfunction syndrome include education, self-care, physical therapy, use of intra-oral appliances, short-term pharmacotherapy, behavioral therapy, and relaxation techniques.

Temporomandibular disorder is most often treated using occlusal splints safely to reduce temporomandibular joint load, and subsequently, clinical symptoms, as a reversible therapy. Occlusal splints need to be used for at least three months to eliminate temporomandibular disorders.

One of physical therapy is laser treatment. Laser treatment on tissues provides a clinical effect called biostimulation, where the basic mechanism occurs at the molecular level.

The low-level laser has non-invasive and inoffensive characteristics at appropriate parameters.

Keywords
Myofacial Pain, Occlusal Splint, Low-Level Laser Therapy
Medical subject headings
Facial Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04257903
Study groupRoleWhat they receive
Occlusal Splint TherapyThe data of patients who previously received occlusal splint therapy were evaluated. Participants in the study received occlusal splint therapy, but the investigator did not assign this intervention specifically to the study participants. Participants received occlusal splint therapy as part of routine medical care, and a researcher studied the effect of occlusal splint therapy.
Low-Level Laser TherapyThe data of patients who previously received Low-Level Laser Therapy were evaluated. Participants in the study received Low-Level Laser Therapy, but the investigator did not assign this intervention specifically to the study participants. Participants received Low-Level Laser Therapy as part of routine medical care, and a researcher studied the effect of Low-Level Laser Therapy.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline Visual Analogue Scale

    Pain intensity during muscle palpations. Scores are ranging from 0 to 10. Higher scores mean a worse outcome.

    Measured: Baseline, one month after the beginning of treatment and two months after the beginning of treatment

Secondary outcomes (1)
  1. Change from Baseline maximum unassisted mouth opening

    Value of Maximum unassisted mouth opening as a centimeter. Scores are ranging from 0 to 45 centimeters. Higher scores mean a better outcome.

    Measured: Baseline, one month after the beginning of treatment and two months after the beginning of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2020
  2. Study start1 Apr 2019
  3. Primary completion1 Apr 2019
  4. Study completion1 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04257903
Sponsor's protocol ID
TUFT-BAEK 2019/114
Status last verified
Feb 2020
First submitted
28 Jan 2020
Last updated
6 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Myofascial Pain and Splints, run by Trakya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline Visual Analogue Scale (time frame: Baseline, one month after the beginning of treatment and two months after the beginning of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in